The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CCTG CO.26 trial: A phase II randomized study of durvalumab plustremelimumab and best supportive care (BSC) vs BSC alone in patients with advanced colorectal carcinoma (CRC) refractory to standard therapies.
 
Eric Xueyu Chen
No Relationships to Disclose
 
Derek J. Jonker
No Relationships to Disclose
 
Hagen F. Kennecke
No Relationships to Disclose
 
Sheryl L. Koski
No Relationships to Disclose
 
Alice Chia-chi Wei
No Relationships to Disclose
 
Nadine M Magoski
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose